Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...41424344454647484950...
CompanyDrug NameStatusIndication Group
Wyeth Enbrel Asthma in Phase IIRespiratory system
Amgen Enbrel Approved in USADermatologicals
Amgen Enbrel in Phase IIIDermatologicals
Wyeth Enbrel Approved in EUMusculoskeletal system
Amgen Enbrel Approved in USAMusculoskeletal system
Amgen Enbrel Approved in USAMusculoskeletal system
Amgen Enbrel Approved in USAMusculoskeletal system
Wyeth Enbrel Approved in USA, EU and JapanAntineoplastic & immunomodulating agents
Novartis Enablex / Emselex Approved in USA and EUGenito urinary system & sex hormones
Novartis Enablex Approved in USAGenito urinary system & sex hormones
Gilead Sciences Emtriva Approved in EUAnti-infectives for systemic use
Watson EmSam Approved in USANervous system
Bavarian Nordic Elstree-BN accomplished Phase IAnti-infectives for systemic use
Sanofi-aventis Eloxatin Approved in USA and EUAntineoplastic & immunomodulating agents
Sanofi-aventis Eloxatin Approved in USAAntineoplastic & immunomodulating agents
Sanofi-aventis Eloxatin Approved in USA and EUAntineoplastic & immunomodulating agents
Sanofi-aventis Eloxantin Approved in USAAntineoplastic & immunomodulating agents
QLT Eligard Approved in USA and EUAntineoplastic & immunomodulating agents
Novartis Elidel in Phase IIDermatologicals
Novartis Elidel in Phase IISensory organs
...41424344454647484950...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.